4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-005730
EVP and Chief Medical Officer gave up 1,624 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Bedrosian Camille L · EVP and Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-01-30 | Shares withheld for taxes : show line 1 in the form | −1,624 | $53.23 | $86,446 | 24,615 | D |
Loading xslF345X03/doc4.xml…